This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Seagen Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations in Cancer Treatment by Phoenix Ho
Introduction
Phoenix Ho is an accomplished inventor based in Bothell, WA (US). He has made significant contributions to the field of cancer treatment, particularly in addressing myeloid malignancies. His innovative work focuses on utilizing nonfucosylated anti-CD70 antibodies to treat conditions such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).
Latest Patents
Phoenix Ho holds a patent for his invention titled "Methods of treating myelodysplastic syndrome and acute myeloid leukemia with nonfucosylated anti-CD70 antibodies." This patent outlines methods that provide new avenues for treating cancer, specifically targeting myeloid malignancies. His work is crucial in advancing therapeutic options for patients suffering from these serious conditions. He has 1 patent to his name.
Career Highlights
Phoenix Ho is currently employed at Seagen Inc., a leading biotechnology company focused on developing innovative therapies for cancer treatment. His role at Seagen allows him to collaborate with other experts in the field and contribute to groundbreaking research that has the potential to save lives.
Collaborations
One of his notable coworkers is Shyra Gardai, with whom he collaborates on various projects aimed at enhancing cancer treatment methodologies. Their combined expertise fosters an environment of innovation and progress in the fight against cancer.
Conclusion
Phoenix Ho's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work at Seagen Inc. and collaboration with fellow researchers highlight the importance of teamwork in advancing medical science.